|
99
|
250
|
1t7rA |
Crystal structure of the androgen receptor ligand binding domain in complex with a fxxlf motif |
|
101
|
249
|
1t76A |
Crystal structure of the androgen receptor ligand binding domain in complex with a wxxvw motif |
|
108
|
249
|
1t7mA |
Crystal structure of the androgen receptor ligand binding domain in complex with a fxxyf motif |
|
101
|
250
|
1t79A |
Crystal structure of the androgen receptor ligand binding domain in complex with a fxxlw motif |
|
96
|
251
|
1sqnA |
Progesterone receptor ligand binding domain with bound norethindrone |
|
100
|
250
|
1t73A |
Crystal structure of the androgen receptor ligand binding domain in complex with a fxxff motif |
|
101
|
250
|
1t7tA |
Crystal structure of the androgen receptor ligand binding domain in complex with 5-alpha dihydrotestosterone |
|
98
|
251
|
1t65A |
Crystal structure of the androgen receptor ligand binding domain with dht and a peptide derived form its physiological coactivator grip1 nr box 2 bound in a non-helical conformation |
|
96
|
251
|
1sr7A |
Progesterone receptor hormone binding domain with bound mometasone furoate |
|
101
|
250
|
1t63A |
Crystal structure of the androgen receptor ligand binding domain with dht and a peptide derived from its physiological coactivator grip1 nr box3 |
|
98
|
249
|
1t74A |
Crystal structure of the androgen receptor ligand binding domain in complex with a wxxlf motif |
|
83
|
225
|
1s9qA |
Crystal structure of the ligand-binding domain of the estrogen-related receptor gamma in complex with 4-hydroxytamoxifen |
|
88
|
289
|
1skxA |
Structural disorder in the complex of human pxr and the macrolide antibiotic rifampicin |
|
98
|
253
|
1s19A |
Crystal structure of vdr ligand binding domain complexed to calcipotriol. |
|
92
|
245
|
1sj0A |
Human estrogen receptor alpha ligand-binding domain in complex with the antagonist ligand 4-d |
|
95
|
253
|
1s0zA |
Crystal structure of the vdr lbd complexed to seocalcitol. |
|
82
|
215
|
1s9pA |
Crystal structure of the ligand-binding domain of the estrogen-related receptor gamma in complex with diethylstilbestrol |
|
102
|
251
|
1s0xA |
Crystal structure of the human roralpha ligand binding domain in complex with cholesterol sulfate at 2.2a |
|
98
|
252
|
1rkgA |
Crystal structure of the rat vitamin d receptor ligand binding domain complexed with 2mbisp and a synthetic peptide containing the nr2 box of drip 205 |
|
79
|
229
|
1rdtA |
Crystal structure of a new rexinoid bound to the rxralpha ligand binding doamin in the rxralpha/ppargamma heterodimer |
|
89
|
243
|
1r1kD |
Crystal structure of the ligand-binding domains of the heterodimer ecr/usp bound to ponasterone a |
|
98
|
253
|
1rkhA |
Crystal structure of the rat vitamin d receptor ligand binding domain complexed with 2am20r and a synthetic peptide containing the nr2 box of drip 205 |
|
84
|
258
|
1r6gA |
Crystal structure of the thyroid hormone receptor beta ligand binding domain in complex with a beta selective compound |
|
79
|
251
|
1r1kA |
Crystal structure of the ligand-binding domains of the heterodimer ecr/usp bound to ponasterone a |
|
78
|
250
|
1r20A |
Crystal structure of the ligand-binding domains of the heterodimer ecr/usp bound to the synthetic agonist byi06830 |
|
88
|
240
|
1r5kA |
Human estrogen receptor alpha ligand-binding domain in complex with gw5638 |
|
95
|
251
|
1rjkA |
Crystal structure of the rat vitamin d receptor ligand binding domain complexed with 2md and a synthetic peptide containing the nr2 box of drip 205 |
|
71
|
242
|
1r20D |
Crystal structure of the ligand-binding domains of the heterodimer ecr/usp bound to the synthetic agonist byi06830 |
|
93
|
272
|
1rdtD |
Crystal structure of a new rexinoid bound to the rxralpha ligand binding doamin in the rxralpha/ppargamma heterodimer |
|
95
|
251
|
1rk3A |
Crystal structure of the rat vitamin d receptor ligand binding domain complexed with 1,25-dihydroxyvitamin d3 and a synthetic peptide containing the nr2 box of drip 205 |
|
91
|
241
|
1qkmA |
Human oestrogen receptor beta ligand-binding domain in complex with partial agonist genistein |
|
86
|
248
|
1qktA |
Mutant estrogen nuclear receptor ligand binding domain complexed with estradiol |
|
85
|
236
|
1qknA |
Rat oestrogen receptor beta ligand-binding domain in complex with antagonist raloxifene |
|
92
|
250
|
1qkuA |
Wild type estrogen nuclear receptor ligand binding domain complexed with estradiol |
|
78
|
233
|
1pzlA |
Crystal structure of hnf4a lbd in complex with the ligand and the coactivator src-1 peptide |
|
89
|
242
|
1pk5A |
Crystal structure of the orphan nuclear receptor lrh-1 |
|
93
|
270
|
1prgA |
Ligand binding domain of the human peroxisome proliferator activated receptor gamma |
|
85
|
253
|
1q4xA |
Crystal structure of human thyroid hormone receptor beta lbd in complex with specific agonist gc-24 |
|
84
|
239
|
1pq9A |
Human lxr beta hormone receptor complexed with t0901317 complex |
|
90
|
239
|
1pqcA |
Human lxr beta hormone receptor complexed with t0901317 |
|
80
|
241
|
1pq6A |
Human lxr beta hormone receptor / gw3965 complex |
|
83
|
236
|
1ovlB |
Crystal structure of nurr1 lbd |
|
85
|
250
|
1p93A |
Crystal structure of the agonist form of glucocorticoid receptor |
|
91
|
230
|
1pduA |
Ligand-binding domain of drosophila orphan nuclear receptor dhr38 |
|
87
|
231
|
1oshA |
A chemical, genetic, and structural analysis of the nuclear bile acid receptor fxr |
|
86
|
244
|
1pcgA |
Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactions |
|
78
|
236
|
1ovlA |
Crystal structure of nurr1 lbd |
|
83
|
244
|
1p8dA |
X-ray crystal structure of lxr ligand binding domain with 24(s),25-epoxycholesterol |
|
79
|
229
|
1osvA |
Structural basis for bile acid binding and activation of the nuclear receptor fxr |
|
73
|
229
|
1ot7A |
Structural basis for 3-deoxy-cdca binding and activation of fxr |
